cystic fibrosis transmembrane conductance regulator (505-511) has been researched along with Amyotrophic Lateral Sclerosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cooper-Knock, J; Garrard, K; Lo, C; Martindale, J; Shaw, P; Williams, T | 1 |
1 other study(ies) available for cystic fibrosis transmembrane conductance regulator (505-511) and Amyotrophic Lateral Sclerosis
Article | Year |
---|---|
Concurrent amyotrophic lateral sclerosis and cystic fibrosis supports common pathways of pathogenesis.
Topics: Adult; Amyotrophic Lateral Sclerosis; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; DNA-Binding Proteins; Female; Humans; Mutation; Peptide Fragments; RNA Splicing | 2013 |